❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Annual reports

Annual reports

Download reports in PDF format:

2025 Single page format Double page format  
2024 Single page format Double page format  
2023 Single page format Double page format  
2022 Single page format Double page format  
2021 Single page format Double page format  
2020 Single page format Double page format Abstract (in Norwegian)
2019 Single page format Double page format Abstract (in Norwegian)
2018 Single page format Double page format Abstract (in Norwegian)
2017 Single page format Double page format  
2016 Single page format Double page format  
2015 Single page format    
2014 Single page format    

 

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

López A, Zobolas J, Dumontier T, Aittokallio T (2026)
Multi-modal learning with incomplete data
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-77212-w, PubMed 42811071

Yaqub S, Valberg M, Bjørnbeth BA, Angelsen JH, Brudvik KW, Eilertsen IA, Fristedt R, Fristrup CW, Gilg S, Hemmingsson O, Isaksson B, Juel IS, Knudsen AR, Larsen PN, Mortensen KE, Olsen IC, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Lothe RA, Taskén K, ASAC Study Group (2026)
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Lancet Gastroenterol Hepatol (in press)
DOI 10.1016/S2468-1253(26)00260-8, PubMed 42777749

Avershina E, Birkeland EE, Bucher-Johannessen C, Rounge TB (2026)
CRISPR-Cas immune repertoires as an ecological record of bacterial interactions with mobile genetic elements in the human gut
Gut Microbes, 18 (1), 2734649
DOI 10.1080/19490976.2026.2734649, PubMed 42768305

More selected publications

Most recent publications

Schuster C, Oppedal IA, Vinnem LI, Abrahamsson EL, Barrett TM, Steinskog ESS, Giercksky Russnes HE, Helland Å (2026)
Targeted ALK inhibition achieving tumour control in metastatic melanoma: a case report
Acta Oncol, 65, 814-817
DOI 10.2340/1651-226X.2026.46424, PubMed 42820355

Ning JF, Davis ZB, Zeb Q, Hinderlie P, Tuininga K, Wang L, Chaudhary S, Vue Y, Ma J, Zhu S, Zhang Y, Seeman ZJ, Malmberg KJ, Valamehr B, Largaespada DA, Zorko N, Felices M, Cichocki F, Miller JS, Chen CC (2026)
Induced pluripotent stem cell-derived natural killer cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Neuro Oncol, 28 (10), 2369-2383
DOI 10.1093/neuonc/noag154, PubMed 42434963

Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol, 99 (1186), 2129-2136
DOI 10.1093/bjr/tqag133, PubMed 42233285

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)